Arthur S. Schneider
Rosalind Franklin University of Medicine and Science
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Arthur S. Schneider.
The American Journal of Medicine | 1966
William N. Valentine; Arthur S. Schneider; Marjorie A. Baughan; Donald E. Paglia; Henry L. Heins
HE human mature erythrocyte is metabolically underprivileged. It lacks a nucleus, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), an intact Krebs’ cycle or cytochrome system and the capacity to perform oxidative phosphorylation. Its metabolic requirements, small but definite, are largely satisfied by the conversion of glucose to lactate via the EmbdenMeyerhof and hexose monophosphate oxidative shunt pathways. Reduced triphosphopyridine nucleotide (NADPH) generated in the latter is recycled to triphosphyridine nucleotide (NADP) chiefly in the process of conversion of oxidized glutathione to the reduced form by the enzyme glutathione reductase. Maintenance of glutathione in the reduced state appears important in protection against certain drug challenges and oxidative stresses. Net synthesis of high energy phosphate bonds in the form of adenosine triphosphate (ATP) is derived from glycolysis, and the Embden-Meyerhof pathway of metabolism of glucose also provides a mechanism whereby NAD is converted to NADH and cycled back
Molecular Immunology | 1986
Clarke J. Halfman; Robert Dowe; Dennis W. Jay; Arthur S. Schneider
The instantaneous effect of dodecyl sulfate (DDS), in the mM concn range, on the binding of monovalent hapten by immunoglobulin was examined. Fluorescence measurements were utilized to study the effect of the detergent on sheep antiserum generated against thyroxin (T4) and against methamphetamine. Haptens were conjugated with the thiocyanate derivative of fluorescein in order to determine hapten binding on the basis of increased fluorescence polarization for the fluorescein-thiocarbamyl-hapten adducts (FT4 or FA) bound to immunoglobulin. Incubation of anti-T4-serum with DDS for 1 hr before the addition of FT4 resulted in diminished binding. The effect occurred at DDS concns greater than 0.1 mM and was essentially complete at a DDS conc of 1 mM. A kinetic study demonstrated a two stage process. An initial, rapid stage, with a half time less than 30 sec accounted for a reduction of immunoglobulin binding by 75%. The remaining 25% binding capacity was lost during a second, much slower phase with a half-time of about 11/2 hr. Prior hapten binding inhibited the effect of DDS. The degree of protection from combining site denaturation afforded by prior hapten binding was limited by the dissociation rate of bound hapten. The major, rapid phase was completely and immediately reversible by dilution. Prolonged incubation in DDS resulted in irreversible denaturation. The overall rate of DDS denaturation of the entire immunoglobulin molecule, as revealed by changes in the circular dichroism spectrum of a sheep gamma globulin fraction, was considerably slower than the denaturation rate of the combining site.
The New England Journal of Medicine | 1967
William N. Valentine; Frank A. Oski; Donald E. Paglia; Marjorie A. Baughan; Arthur S. Schneider; J. Lawrence Naiman
Best Practice & Research Clinical Haematology | 2000
Arthur S. Schneider
Journal of Clinical Investigation | 1964
George A. Koutras; Masao Hattori; Arthur S. Schneider; Frank G. Ebaugh; William N. Valentine
Blood Cells Molecules and Diseases | 1996
Arthur S. Schneider; Michel Cohen-Solal
Blood | 2000
Colette Valentin; Serge Pissard; Josiane Martin; Delphine Héron; Philippe Labrune; Marie-Odile Livet; Michèle Mayer; Terri Gelbart; Arthur S. Schneider; Isabelle Max-Audit; Michel Cohen-Solal
Blood Cells Molecules and Diseases | 1996
Arthur S. Schneider; Beryl Westwood; Catherine Yim; Michel Cohen-Solal; Raymonde Rosa; Richard J. Labotka; Stefan Eber; Raoul Wolf; Ahti Lammi; Ernest Beutler
Blood | 1998
Arthur S. Schneider; Linda Forman; Beryl Westwood; Catherine Yim; James S Lin; Satinder Singh; Ernest Beutler
Analytical Chemistry | 1981
Clarke J. Halfman; Arthur S. Schneider